Newsletter Nuclear Medicine, Proton Therapy and Brachytherapy

LOUVAIN-LA-NEUVE, Belgium - Oct. 9, 2014 - PRLog -- MEDraysintell, the Strategic Intelligence Expert for the medical radiation industry, is launching today its first quarterly newsletter, providing key facts about Nuclear Medicine, Proton Therapy and Brachytherapy.

Nuclear Medicine, Proton Therapy and Brachytherapy are niche markets which together represents far less than 0.1% of the global health expenditures, but represents some of the most exciting healthcare technologies. There is an increasing interest from investors and industry as new technologies and products are being marketed or under development. Following the release of the most recent expert reports about Proton Therapy and Nuclear Medicine, MEDraysintell will very soon publish its new report dedicated to Brachytherapy.

If you are interested in receiving this newsletter and the following ones, please just send us your contact details at: peg@medraysintell.com


About MEDraysintell
Medical Radiation Strategic Intelligence Experts
Bringing value to Businesses and Investors!


MEDraysintell was created in 2013 by Paul-Emmanuel Goethals (CSIntell) and Richard Zimmermann (Chrysalium Consulting). It combines over 40 years of experience in radiotherapy, particle therapy and nuclear medicine. We aim to form an international team of experts in the field of Medical Radiation industry to provide Strategic Intelligence in nuclear medicine, radiotherapy, proton therapy and brachytherapy to help our clients better understand the markets, competitive environment as well as the potential of merger and acquisitions (M&A) and technology development.
MEDraysintell wants to support in their decisional process manufacturers of radiopharmaceuticals or therapeutic radioisotopes, suppliers of equipment and software as well as investors interested by this industry. www.medraysintell.com